Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics
Objectives and methods The cysteinyl leukotriene receptor 2 (CYSLTR2) gene on chromosome 13q14.12-q21.1 encodes a receptor for CYSLTs, potent biological mediators in the pathogenesis of asthma, particularly that associated with aspirin intolerance (AIA). In an effort to discover additional polymorphism(s), the variant(s) of which have been implicated in asthma and aspirin intolerance, we scrutinized genetic polymorphisms of the CYSLTR2 gene, and evaluated this locus as a potential candidate for asthma.
Results DNA sequencing in 24 Koreans of the 5-kb region of the CYSLTR2 gene, including the B1500-bp promoter region, revealed four sequence variants: one in the 5 0 -flanking region (c. , and five haplotypes were constructed. The SNPs and haplotypes were not associated with risk of asthma development, but were significantly associated with aspirin intolerance. The frequencies of rare alleles on c. -819T > G, c.2078C > T, and c.2534A > G were higher in subjects with AIA than in subjects with aspirin-tolerant asthma (P = 0.013-0.031). Asthmatics who had rare alleles for c. -819T > G, c.2078C > T or c.2534A > G exhibited a more pronounced fall in FEV 1 after aspirin provocation than did those who carried the common allele (P = 0.03-0.009). Asthmatics carrying ht2 (TTGA) also showed a more pronounced decrease in FEV 1 % after aspirin provocation than those carrying ht1 (GCGA) (P = 0.006). These associations were even stronger when combined with LTC4S polymorphisms ( 
Introduction
Aspirin-intolerant asthma (AIA) refers to the development of bronchoconstriction in asthmatic individuals following the ingestion of aspirin or other non-steroidal anti-inflammatory drugs. This syndrome is characterized by the 'aspirin triad' [1] syndrome of aspirin hypersensitivity, bronchial asthma, and chronic rhinosinusitis with nasal polyposis. AIA affects about 5-10% of adult asthmatics, and occurs more frequently in women [2] . Although the pathogenesis of AIA has not been elucidated completely, a two-compartment model has been proposed, in which both the augmentation of cysteinyl leukotriene (CysLT) production and the overexpression of the CysLT receptor on inflammatory cells occur within the respiratory tract [3] . The over-production of CysLTs has been demonstrated in the airways and circulation of asthmatics who are intolerant to aspirin [4] [5] [6] . The enhanced activities of key synthetic enzymes, such as leukotriene C4 synthase (LTC4S) [7] and 5-lipoxygenase (ALOX5) [8] , have been implicated in the elevated production of CysLTs in patients with AIA. In addition to enhanced production of CysLTs, AIA patients have greater airway hyperresponsiveness on inhalation challenge with leukotriene E 4 (LTE 4 ) than do aspirin-tolerant patients [9] . These data suggest the presence of augmented target-organ responsiveness to the CysLTs.
CysLTs are important inflammatory mediators in the development of asthma, as they mediate bronchoconstriction while increasing mucus secretion, vascular permeability, and cellular infiltration [10] [11] . The CysLTs exert their biological actions by binding two types of G-protein-coupled seven-transmembrane receptors: cysteinyl leukotriene receptor 1 (CYSLTR1; MIM 300201), which is sensitive to the asthma drugs montelukast, zafirlukast and pranlukast [12] [13] ; and CYSLTR2 [14] . CYSLTR2 is expressed by lung interstitial macrophages [15] , pulmonary vascular smooth muscle, endothelium [16] [17] [18] , eosinophils [19] , and mast cells [20] , which raises the possibility that CYSLTR2 plays an important role in allergic inflammation. Furthermore, the CYSLTR2 gene is located on chromosome 13q14.2-21.1, which is close to a locus for increased risk of asthma in various populations [21, 22] . Recently, CYSLTR2 gene polymorphisms have been associated with the risk of asthma development in Caucasian [23] and Japanese [24] populations. However, to the best of our knowledge, there has been no previous analysis of potential associations between CYSLTR2 gene polymorphisms and aspirin intolerance in asthmatics. In an effort to discover additional polymorphism(s) in genes, the variants of which have been implicated in aspirin intolerance, we scrutinized the genetic polymorphisms of the CYSLTR2 gene, and evaluated this locus as a potential candidate for aspirin intolerance in asthmatics. DNA samples from twenty-four individuals were screened for polymorphisms within the complete gene, which included the B1500-bp promoter region of CYSLTR2, and four sequence variants were identified. The SNPs were analyzed in a Korean population (N = 642), and statistical analyses were performed to examine the genetic effects on asthma and aspirin intolerance. Furthermore, we analyzed the interaction between the CYSLTR2 gene and other candidate genes, such as those for ALOX5 and LTC4S, which have been implicated in the development of aspirin intolerance in asthmatics [7, 8, [25] [26] [27] . In this report, we present four nucleotide polymorphisms in the CYSLTR2 gene, together with the results of the association and gene-gene interaction studies.
Methods

Subjects
The subjects (N = 642) were recruited from the Asthma Genome Research Center, comprising Soonchunhyang University Bucheon Hospital, Seoul Hospital, and Ajuo University Hospital, Korea. All of the subjects were Korean. The asthmatics (N = 490) had compatible clinical symptoms and physical characteristics. Each patient showed airway reversibility, as documented by inhalant bronchodilator-induced improvement of more than 15% of forced expiratory volume in 1 second (FEV 1 ) and/or airway hyperreactivity of less than 10 mg/ml of methacholine. Two hundred asthmatics were divided into two groups: the first group (N = 158) underwent the lysine-aspirin (L-ASA) bronchoprovocation test, and the second group (N = 42) underwent the oral provocation test. The L-ASA bronchoprovocation test was performed with increasing doses of aspirin (75-300 mg/ml Althargyl; Arthromedica, Switzerland) [28] . The oral provocation test was performed with increasing doses of aspirin (10-650 mg Astrix; Mayne Pharma Ltd., Melbourne, Australia) using a slightly modified version of the method described previously [29] . Changes in FEV 1 were followed for 5 h after the last dose of aspirin challenge. Aspirin-induced changes in FEV 1 (percentages) were calculated as the pre-challenge FEV 1 , minus the postchallenge FEV 1 , divided by the pre-challenge FEV 1 . Subjects who showed only extrabronchial symptoms without a fall in FEV 1 of less than 15% were excluded from the association analysis. Normal controls (N = 152) were recruited from members of the general population who answered negatively to a screening questionnaire regarding respiratory symptoms, had no past history of ASA hypersensitivity, had FEV 1 values > 80% predicted, PC 20 methacholine > 25 mg/ml, and normal findings on simple chest radiograms. Skin prick tests were performed with 24 common aeroallergens (Bencard Co., Ltd., Brentford, UK) [8] . Atopy was defined as one or more positive reactions ( > 3 mm in diameter) on the skin prick test. Total immunoglobulin E (IgE) was measured using the UniCAP system (Pharmacia Diagnostics, Uppsala, Sweden). All subjects gave informed consent to participate in the study, and the protocols were approved by the local ethics committees.
The clinical characteristics of the study subjects are summarized in Table 1 . There were significant differences in mean age, sex distribution, prevalence of smoking, and prevalence of atopy between the normal controls and the asthmatics or the ASA-challenged asthmatics (P < 0.001). The initial FEV 1 values of the asthmatics were significantly lower than those of the normal controls (P < 0.001). The maximum fall in FEV 1 during the follow-up period of 5 h post-challenge with aspirin was used as the value for aspirin-induced fall in FEV 1 . Among the asthmatics, 200 subjects underwent the aspirin provocation test. Aspirin-induced changes in FEV 1 % ranged from -15% to 68% (mean ± SE, 10.41 ± 1.07%).
Sequencing analysis of the human CYSLTR2 gene
The entire CYSLTR2 gene was sequenced, including the promoter region (B1.5. kb), to discover single nucleotide polymorphisms (SNPs) in 24 DNA samples from Korean subjects. DNA sequencing was performed using the ABI PRISM 3700 DNA analyzer (Applied Biosystems, Foster City, California, USA). Nine primer sets, which were based on GenBank sequences (reference genome sequence NT_024524, released on 23 January 2004), were designed for the amplification and sequencing analyses. Information regarding the primers is available on our website (http://www.snp-genetics.com/user/additional_ list.asp). Sequence variants were verified using chromatograms. In order to compare the allele frequencies of Korean CYSLTR2 SNPs with those of other major ethnic groups, we genotyped 50 Caucasian and 50 AfricanAmerican DNA samples, which were obtained from the -444A > C, rs730012]) were genotyped as described previously [8] .
Genotyping by single-base extension (SBE) and electrophoresis
For the genotyping of polymorphic sites, amplification and extension primers were designed for single-base extension (SBE) analysis [30] . Primer extension reactions were performed with the SNaPshot ddNTP Primer Extension Kit (Applied Biosystems). Information regarding the primers is available on our website (http:// www.snp-genetics.com/user/additional_list.asp). In order to clean up the primer extension reaction, 1 U SAP (shrimp alkaline phosphatase) was added to the reaction mixture, and the mixture was incubated at 371C for 1 h, followed by incubation for 15 min at 721C for enzyme inactivation. The DNA samples, which contained the extension products, and the Genescan 120 Liz size standard solution were added to Hi-Di formamide (Applied Biosystems), according to the manufacturer's recommendations. The mixture was incubated at 951C for 5 min, followed by 5 min on ice. Electrophoresis was then performed using the ABI Prism 3100 Genetic Analyzer. The results were analyzed using the ABI Prism GeneScan software and the Genotyper system (Applied Biosystems).
Statistics
We employed a widely used measure of linkage disequilibrium between all pairs of biallelic loci, Lewontin's D 0 (|D 0 |) and r 2 [31] . The haplotypes of the individuals were inferred using the EM algorithm. The genetic effects of inferred haplotypes were analyzed in the same way as the SNPs. The distributions of CYSLTR2 SNP genotypes and haplotypes among the asthmatics and the normal subjects were analyzed with logistic regression models that controlled for age (continuous value), sex (male = 0, female = 1), atopy status (non-atopy = 0, atopy = 1), and smoking status (non-smoker = 0, exsmoker = 1, smoker = 2) as co-variables. The continuous variable of FEV 1 change induced by aspirin provocation was subjected to a simple linear regression analysis, and the differences in the values among the genotypes or haplotypes were examined using a linear regression model that controlled for age, sex, atopy status, and smoking status as co-variables. The interactions between genes in terms of the FEV1 changes induced by aspirin provocation were evaluated using the same methods. The data were managed and analyzed using the SAS ver. 8.1 (SAS Inc., Cary, North Carolina, USA) and SPSS ver. 10.0 (SPSS Inc., Chicago, Illinois, USA) software packages. A P value of 0.05 or lower was regarded as statistically significant.
Results
Identification and frequency of single nucleotide polymorphisms of the cysteinyl leukotriene receptor 2 DNA sequencing of 24 individuals identified four sequence variants within the complete gene, which included the B1500-bp promoter region of CYSLTR2: one in the 5 0 -flanking region (c. -819T > G), two in the 3 0 -UTR region (c.2078C > T and c.2534A > G), and one in the 3 0 _flanking region (c.2545 + 297A > G) ( Table 2 , Fig. 1a) . One of the variants (c.2078C > T) represents novel SNP. Four SNPs were genotyped for the asthma genetic association study. The frequencies of these four SNPs in the Korean population (N = 642) were: 0.499 Table 2 ). The genotype distributions of all loci were in Hardy-Weinberg equilibrium (P > 0.05). The number of cases and controls were 490 and 152, which were moderate in the association analysis study of the complex diseases such as asthma. The linkage disequilibrium coefficients (|D 0 |) and r 2 among the SNPs were calculated for all of the study subjects (Fig. 1c) . Strong LDs were observed between SNPs (|D 0 | > 0.97) along the gene. Five haplotypes were constructed. Significant differences in the frequencies of the SNPs and haplotypes were observed among the three ethnic groups (Table 2, Fig. 1b) .
Association of SNPs with asthma phenotype and aspirin-induced FEV 1 fall in asthmatics
The associations between the four CYSLTR2 gene SNPs and risk of asthma were analyzed. The statistic analyses are summarized in Table 3 . Although 80% power to detect a disease effect was obtained in this study (calculated by 30% of the allele frequency, 490 cases/152 controls, and 2.0 odds ratio at a significance level of 0.01), there were no significant associations between the SNPs or haplotypes and asthma development ( Table 3) .
Association of CYSLTR2 polymorphisms with the risk of aspirin intolerance in asthmatics
All of the single SNPs and the five haplotypes were analyzed for association with the risk of aspirin intolerance using multiple logistic regression models in the asthmatics (Table 4 ). The association analysis revealed that three SNPs (CYSLTR2 c. -819T > G, CYSLTR2 c.2078C > T, and CYSLTR2 c.2534A > G) were significantly associated with aspirin intolerance with an odds ratio of 2.02-2.28 in the co-dominant model (P = 0.013-0.031). The frequencies of rare alleles in CYSLTR2 c. -819T > G, CYSLTR2 c.2078C > T, and CYSLTR2 c.2534A > G were higher for aspirin-intolerant asthmatics than for aspirintolerant asthmatics.
Since the percentage FEV 1 fall after aspirin provocation is the most important parameter for the diagnosis of aspirin intolerance in asthmatics, we investigated the associations between genotypes or haplotypes and the percentage of FEV 1 fall following aspirin challenge using multiple linear regression analysis (Table 5) Gene-gene interactions between CYSLTR2 and LTC4S with regard to FEV 1 fall caused by aspirin challenge in asthmatics
Previously, we reported the association of ALOX5 gene SNPs with aspirin-intolerant asthma [8] . In addition, a recent study has suggested the involvement of LTC4S gene in aspirin intolerant asthma in a Polish population [32] . Thus, we investigated the gene-gene interactions between these genes and CYSLTR2. The association of CYSLTR2 c.2078C > T and CYSLTR2 c.2534A > G with the percentage FEV 1 fall following aspirin challenge became more obvious when paired analysis was performed with LTC4S -444A > C (c. -444A > C; Table 6 ). The asthmatics with rare allele homozygotes of CYSLTR2 c.2078 and the common allele homozygote of LTC4S -444 (c. -444) showed the greatest FEV 1 fall (P = 0.026 and P = 0.007; co-dominant and recessive models, respectively). In addition, the asthmatics with rare allele homozygotes of CYSLTR2 c.2534 and the common allele homozygote of LTC4S -444 (c. -444) showed the greatest FEV 1 fall (P = 0.011 and P = 0.003; co-dominant and recessive models, respectively). The P values of recessive models were still significant after the correction for multiple comparison (P < 0.017). This genetic effect of CYSLTR2 c.2078C > T and CYSLTR2 c.2534A > G on FEV 1 fall was not observed in the asthmatics who carried the rare allele of LTC4S -444A > C (c. -444A > C). No significant interactions were observed between CYSLTR2 and the ALOX5 polymorphisms (data not shown).
Discussion
CysLTs are important inflammatory mediators in the development of asthma by mediating bronchoconstriction, as well as increasing mucus secretion, vascular permeability, and cellular infiltration [10, 11] . The CysLTs exert their biological actions by binding two types of G-protein-coupled-seven-transmembrane receptors: cysteinyl leukotriene receptor 1 (CYSLTR1; MIM 300201), and CYSLTR2 [14] . Because CYSLTR2 mRNA is abundantly expressed at high levels in eosinophils, it is thought that CYSLTR2 may have an important physiological role in eosinophils, main effect cells in asthma, especially AIA [19] . Although the pathogenesis of aspirin intolerance has not been elucidated completely, a twocompartment model, in which both augmentation of cysteinyl leukotriene production and overexpression of the CysLT receptor on inflammatory cells, especially eosinophils, may be active within the respiratory tract [3] .
In the present study, we identified sequence variants within the complete gene by direct DNA sequencing of 24 Korean individuals. Our strategy for SNP discovery is aimed to find common SNPs in Korean population, which enable us to have statistical powers for genetic association study of asthma. With 24 samples (48 chromosomes), we might be able to expect that more than 90% of common SNPs with frequency greater than 0.05 [33] and that, when we are focusing on common haplotypes in genes, analysis of 24 samples (48 chromosomes) might able to capture major LD and haplotype information in a population.
We are the first to show that asthmatics with allele polymorphisms of CYSLTR2 c. -819T > G, CYSLTR2 c.2078C > T, and CYSLTR2 c.2534A > G and the haplotype ht1 or ht2 have decreased FEV 1 after aspirin provocation. These data indicate that CYSLTR2 polymorphisms are associated with aspirin intolerance in asthmatics. c. -819T > G was located within the promoter region. This region has putative transcription factor-binding sites (TFSEARCH, Searching Transcription Factor-Binding Sites ver. 1.3; putative score > 0.85) for HFH-2 and SRY. Although these factors have been identified in mice, it suggests that the human homologues of these factors may play a role on the CYSLTR2 transcription, which could be altered according to genotypes on c. -819T > G. The other three SNPs were located in the 3 0 -UTR or downstream of the CYSLTR2 gene. Strong LDs were noted between the polymorphisms of the three alleles. Subjects with the ht1 haplotype, which is composed of the common alleles of four SNPs, were susceptible to aspirin intolerance. These results suggest that the SNPs of CystLTR2 may affect the efficiency of its transcription, with tight linkage to the 3 0 UTR variations, or that the SNPs themselves on the 3 0 UTR may affect the stability of its mRNA. The functional effects of these SNPs on its transcription should be identified.
The biological activities of CysLTs reflect the consequences of binding to their receptors, CYSLTR1 and CYSLTR2, on the surfaces of target cells [14] . CYSLTR1, which is located on Xq13-21, is a G-protein-coupled seven-transmembrane receptor that is expressed primarily in airway smooth muscle, eosinophils, macrophages, and splenocytes. Sousa et al. [3] have reported that the number of cells that expressed CYSLTR1 in the nasal mucosa was significantly higher in aspirin-intolerant asthmatics with chronic rhinosinusitis than in aspirintolerant patients, which suggests that CYSLTR1 overexpression is crucial to the pathogenesis of aspirin hypersensitivity. CysLTs bind to CYSLTR1 with a rank order of potency of LTD 4 > LTC 4 > LTE 4 [34] , and the receptor is antagonized selectively by currently available leukotriene modifiers, such as montelukast, pranlukast and zafirlukast [12, 13] . However, clinical studies have demonstrated that responses to CYSLTR1 antagonists are highly variable, and that about 30% of asthmatics do not respond to this treatment [35, 36] . In our previous study [8] , we could not find any association between CYSLTR1 + 927T > C (c.927T > C, rs320995) and aspirin intolerance. Alternatively, CYSLTR2 may be linked to the development of aspirin intolerance in asthmatics.
The differential expression patterns of CYSLTR1 and CYSLTR2 in the lung indicate that these receptors have different and possibly complementary roles in this tissue. Although the function of the more recently discovered CYSLTR2 has not been fully resolved, protein expression data suggest that the main role of CYSLTR2 in the lung is mediated through effects on macrophages and lung smooth muscles. While macrophages themselves are not thought to play a primary role in airway inflammation, they contribute to inflammatory processes and airway remodeling. Macrophages provide specific cytokine signals through the secretion of modulators, such as interleukin-10 and macrophage-derived chemokine (MDC) [37, 38] . MDC expression is up-regulated by T helper 2 (Th2)-type cytokines and prostaglandins, causing dendritic cell and Th2 cell migration, and is highly expressed in lesions related to airway hypersensitivity. The specific effects of LTD 4 on macrophages are not well-defined. LTD 4 delivered intranasally to mice augmented the level of macrophages in bronchoalveolar lavage fluid [39] , which suggests a possible role in macrophage chemotaxis.
The CYSLTR2 gene maps to 13q14 near a locus for atopic asthma, and the rank order of CysLT potency has been reported as LTC 4 = LTD 4 > LTE 4 [15, 34, 40, 41] . Recently, Thompson et al. [42] reported that the Met202Val variant of CYSLTR2 was associated with atopy in subjects from Tristan da Cunha. More recently, Pillai and colleagues [23] reported that this variant reduced the affinity of CYSLTR2 for LTD 4 , and was associated with asthma in the transmission disequilibrium test (TDT) study. However, in the present study, we did not identify the Met201Val (p.M201V) variant of CYSLTR2 ( + 601A > G [c.601A > G]) in 24 Korean subjects, which was perhaps due to the very low frequency of this rare allele (3%), as noted in the study population of Pillai and colleagues [23] , and to the fact that this variant has not been detected in the Japanese population [24] . The CYSLTR2 polymorphism varies greatly among different ethnic groups (Table 2 ). Fukai and colleagues [24] have reported that -1220A > C (c. -1220A > C) increases susceptibility to asthma in the Japanese population. However, in the present study, we did not identify this variant, which may be related to the low frequency of this rare allele (7%) in the Japanese population [24] .
The enhanced activities of key synthetic enzymes or receptors [7] , possibly determined genetically [13] , have been implicated as the cause of aspirin intolerance in certain asthmatics. Sanak et al. [25, 27] showed in a Polish population that aspirin intolerance was associated with the LTC4S -444A > C (c. -444A > C) polymorphism, which has an additional responsive element for histone H4 transcription factor-2, and which increases the transcription rate of the gene both in vitro and in vivo. We have also reported previously that the aspirinintolerant phenotype is associated with the haplotype of ALOX5-ht1[G-C-G-A] and ALOX5 + 1708G > A (c. -42-1658G > A). Based on the association of aspirin intolerance with polymorphisms of key synthetic genes and, as shown in this study, with CYSLTR2 gene polymorphisms, we evaluated the interactions between the genes for CYSLTR2, 5-lipoxygenase, and LTC 4 S. As shown in Table  6 , there was an association between the genetic effects of CYSLTR2 c.2078C > T and CYSLTR2 c.2534A > G and -444A > C (c. -444A > C) on the LTC4S gene in terms of FEV 1 fall caused by aspirin challenge in asthmatics; this effect was more significant than the effect of CYSLTR2 c.2078C > T or CYSLTR2 c.2534A > G alone. These results strongly suggest that different gene polymorphisms may act co-operatively to influence the development of aspirin intolerance in asthmatics.
To date, several genetic and functional studies have demonstrated the association of LTC4S -444A > C (c.
-444A > C) with AIA and the urinary concentration of LTE 4 . In a Japanese population, Kawagishi et al. [26] reported that LTC4S -444 A (c. -444A) allele homozygote showed a greater increase of urinary LTE 4 after aspirin challenge; this was not observed in the Polish population [25] . A possible explanation for the genetic interaction between CYSLTR2 and LTC4S is that the altered concentration of LTC 4 , which is caused by the LTC4S -444 (c. -444) polymorphism, may differentially affect aspirin intolerance, according to the CYSLTR2 gene polymorphisms. Therefore, the nature of the genetic interaction and functional evidence for this phenomenon need to be clarified.
In summary, we have identified four human CYSLTR2 gene polymorphisms, including one novel SNP, which are associated with the development of aspirin intolerance in asthmatics. In addition, these associations are more pronounced when paired with polymorphisms of the LTC4S gene. This information on genetic polymorphisms of the important CYSLTR2 gene may be useful in the development of new methods to diagnose aspirin intolerance, and new strategies for the control of aspirin intolerance.
